Robertm Plenge News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Robertm plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Robertm Plenge Today - Breaking & Trending Today
Atria Investments Inc increased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 160,279 shares of the biopharmaceutical company’s stock after acquiring an additional 7,402 shares during the period. Atria Investments Inc’s holdings […] ....
American International Group Inc. boosted its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.4% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 562,489 shares of the biopharmaceutical company’s stock after purchasing an additional 2,160 shares during the period. American International Group Inc.’s holdings in Bristol-Myers […] ....
Sandy Spring Bank cut its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.9% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 119,472 shares of the biopharmaceutical company’s stock after selling 2,350 shares during the period. Sandy Spring Bank’s […] ....
B&D White Capital Company LLC bought a new stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 98,375 shares of the biopharmaceutical company’s stock, valued at approximately $6,291,000. Bristol-Myers Squibb comprises […] ....
New York Life Investment Management LLC cut its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 339,166 shares of the biopharmaceutical company’s stock after selling 2,358 shares during the […] ....